Predictors of vision impairment in Multiple Sclerosis

Visual impairment significantly alters the quality of life of people with Multiple Sclerosis (MS). The objective of this study was to identify predictors (independent variables) of visual outcomes, and to define their relationship with neurological disability and retinal atrophy when assessed by optical coherence tomography (OCT). We performed a cross-sectional analysis of 119 consecutive patients with MS, assessing vision using high contrast visual acuity (LogMar), 2.5% and 1.25% low contrast visual acuity (Sloan charts), and color vision (Hardy-Rand-Rittler plates). Quality of vision is a patient reported outcome based on an individual's unique perception of his or her vision and was assessed with the Visual Functioning Questionnaire-25 (VFQ-25) with the 10 neuro-ophthalmologic items. MS disability was assessed using the expanded disability status scale (EDSS), the MS functional composite (MSFC) and the brief repetitive battery-neuropsychology (BRB-N). Retinal atrophy was assessed using spectral domain OCT, measuring the thickness of the peripapillar retinal nerve fiber layer (pRNFL) and the volume of the ganglion cell plus inner plexiform layer (GCIPL). The vision of patients with MS was impaired, particularly in eyes with prior optic neuritis. Retinal atrophy (pRNFL and GCIPL) was closely associated with impaired low contrast vision and color vision, whereas the volume of the GCIPL showed a trend (p = 0.092) to be associated with quality of vision. Multiple regression analysis revealed that EDSS was an explanatory variable for high contrast vision after stepwise analysis, GCIPL volume for low contrast vision, and GCIPL volume and EDSS for color vision. The explanatory variables for quality of vision were high contrast vision and color vision. In summary, quality of vision in MS depends on the impairment of high contrast visual acuity and color vision due to the disease.

[1]  D. Pélisson,et al.  Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability , 2013, Multiple sclerosis.

[2]  M. Maguire,et al.  New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis , 2000, Multiple sclerosis.

[3]  Sara Llufriu,et al.  Trans‐synaptic axonal degeneration in the visual pathway in multiple sclerosis , 2014, Annals of neurology.

[4]  F. Paul,et al.  Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis , 2014, BMC Neurology.

[5]  R. Marrie,et al.  “Seeing” in NARCOMS: a look at vision-related quality of life in the NARCOMS registry , 2013, Multiple sclerosis.

[6]  O Garcea,et al.  Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test , 2006, Multiple sclerosis.

[7]  I. Zubizarreta,et al.  The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS , 2014, BMC Research Notes.

[8]  P. Villoslada,et al.  Color vision is strongly associated with retinal thinning in multiple sclerosis , 2012, Multiple sclerosis.

[9]  K. Trinkaus,et al.  Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis. , 2016, Multiple sclerosis and related disorders.

[10]  Hiroshi Ishikawa,et al.  Ganglion cell loss in relation to visual disability in multiple sclerosis. , 2012, Ophthalmology.

[11]  S. Reingold,et al.  The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment , 1999, Multiple sclerosis.

[12]  B. Uitdehaag,et al.  Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis , 2017, Multiple sclerosis.

[13]  Alexander Klistorner,et al.  Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study , 2016, The Lancet Neurology.

[14]  M. Maguire,et al.  Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. , 2002, American journal of ophthalmology.

[15]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[16]  M. Maguire,et al.  Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. , 2006, American journal of ophthalmology.

[17]  Christian Confavreux,et al.  Recommendations from the national multiple sclerosis society clinical outcomes assessment task force , 1997, Annals of neurology.

[18]  I. Zubizarreta,et al.  Early retinal atrophy predicts long-term visual impairment after acute optic neuritis , 2017, Multiple sclerosis.

[19]  Pablo Villoslada,et al.  The APOSTEL recommendations for reporting quantitative optical coherence tomography studies , 2016, Neurology.

[20]  Carol Lakkis,et al.  The new Richmond HRR pseudoisochromatic test for colour vision is better than the Ishihara test , 2006, Clinical & experimental optometry.

[21]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[22]  W. Omulecki,et al.  Evaluation of contrast sensitivity measurements after retrobulbar optic neuritis in Multiple Sclerosis , 2014, Graefe's Archive for Clinical and Experimental Ophthalmology.

[23]  Fiona Costello,et al.  Vision Disturbances in Multiple Sclerosis , 2016, Seminars in Neurology.

[24]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.

[25]  P. Villoslada,et al.  Color vision impairment in multiple sclerosis points to retinal ganglion cell damage , 2015, Journal of Neurology.

[26]  David H. Miller,et al.  Vision and vision-related outcome measures in multiple sclerosis , 2014, Brain : a journal of neurology.

[27]  S. Gold,et al.  Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable , 2008, Multiple sclerosis.

[28]  Lynn D. Hudson,et al.  Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis , 2017, Multiple sclerosis.

[29]  Sara Llufriu,et al.  Colour vision impairment is associated with disease severity in multiple sclerosis , 2014, Multiple sclerosis.